Spyre Therapeutics (SYRE) Preferred Shares (2023 - 2025)
Historic Preferred Shares for Spyre Therapeutics (SYRE) over the last 3 years, with Q3 2025 value amounting to $146.4 million.
- Spyre Therapeutics' Preferred Shares changed 0.0% to $146.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $146.4 million for FY2024, which is 2082.01% down from last year.
- Per Spyre Therapeutics' latest filing, its Preferred Shares stood at $146.4 million for Q3 2025, which was down 0.0% from $146.4 million recorded in Q2 2025.
- Spyre Therapeutics' Preferred Shares' 5-year high stood at $184.9 million during Q4 2023, with a 5-year trough of $146.4 million in Q2 2024.
- In the last 3 years, Spyre Therapeutics' Preferred Shares had a median value of $146.4 million in 2024 and averaged $156.1 million.
- Per our database at Business Quant, Spyre Therapeutics' Preferred Shares crashed by 2082.01% in 2024 and then changed by 0.0% in 2025.
- Spyre Therapeutics' Preferred Shares (Quarter) stood at $184.9 million in 2023, then dropped by 20.82% to $146.4 million in 2024, then changed by 0.0% to $146.4 million in 2025.
- Its Preferred Shares was $146.4 million in Q3 2025, compared to $146.4 million in Q2 2025 and $146.4 million in Q1 2025.